XKRX036180
Market cap18mUSD
Aug 19, Last price
489.00KRW
Name
GW Vitek Co Ltd
Chart & Performance
Profile
GW Vitek Co Ltd is a South Korean company operating in scientific and technical instruments industry. The company is engaged in manufacturing of life science equipment, process equipment, bio reagent, laboratory basic equipment, imaging equipment, and metabolic analysis service.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 47,923,293 -8.76% | 52,525,588 -0.09% | 52,573,686 0.15% | |||||||
Cost of revenue | 47,068,155 | 49,987,545 | 45,973,045 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 855,138 | 2,538,043 | 6,600,641 | |||||||
NOPBT Margin | 1.78% | 4.83% | 12.56% | |||||||
Operating Taxes | (39,017) | (937,281) | (638,061) | |||||||
Tax Rate | ||||||||||
NOPAT | 894,155 | 3,475,324 | 7,238,703 | |||||||
Net income | (14,927,804) 67.52% | (8,911,270) 78.18% | (5,001,172) -1.29% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 3,900,000 | (210,952) | 1,999,999 | |||||||
BB yield | -10.58% | 0.64% | -2.86% | |||||||
Debt | ||||||||||
Debt current | 9,135,575 | 10,668,806 | 2,091,288 | |||||||
Long-term debt | 6,345,707 | 7,539,096 | 8,161,941 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 250 | 110 | 9,999 | |||||||
Net debt | (1,201,270) | 1,705,084 | 1,045,238 | |||||||
Cash flow | ||||||||||
Cash from operating activities | (10,547,801) | (9,454,849) | 1,218,973 | |||||||
CAPEX | (764,061) | (6,771,552) | (1,274,896) | |||||||
Cash from investing activities | 3,423,789 | (13,285,804) | 6,803,616 | |||||||
Cash from financing activities | 6,063,204 | 18,108,627 | (5,580,462) | |||||||
FCF | 5,739,482 | (15,486,634) | 8,403,685 | |||||||
Balance | ||||||||||
Cash | 5,437,483 | 8,410,301 | 21,154,774 | |||||||
Long term investments | 11,245,070 | 8,092,518 | (11,946,783) | |||||||
Excess cash | 14,286,388 | 13,876,539 | 6,579,306 | |||||||
Stockholders' equity | (11,546,897) | (1,379,996) | (6,150,119) | |||||||
Invested Capital | 51,672,360 | 52,087,482 | 35,235,024 | |||||||
ROIC | 1.72% | 7.96% | 21.04% | |||||||
ROCE | 1.99% | 5.01% | 22.69% | |||||||
EV | ||||||||||
Common stock shares outstanding | 57,937 | 45,192 | 29,947 | |||||||
Price | 636.00 -12.76% | 729.00 -68.78% | 2,335.00 | |||||||
Market cap | 36,848,008 11.85% | 32,945,104 -52.89% | 69,926,570 | |||||||
EV | 38,555,735 | 39,477,969 | 70,971,808 | |||||||
EBITDA | 3,022,291 | 3,809,877 | 7,051,434 | |||||||
EV/EBITDA | 12.76 | 10.36 | 10.06 | |||||||
Interest | 1,568,523 | 1,835,169 | 2,353,547 | |||||||
Interest/NOPBT | 183.42% | 72.31% | 35.66% |